Emeren Deferred Long Term Liab from 2010 to 2024
| SOL Stock | USD 1.78 0.08 4.30% |
Deferred Long Term Liabilities | First Reported 2010-12-31 | Previous Quarter 14.7 M | Current Value 13.1 M | Quarterly Volatility 918 K |
Check Emeren financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Emeren's main balance sheet or income statement drivers, such as Depreciation And Amortization of 7.1 M, Interest Expense of 77.9 K or Selling General Administrative of 23.5 M, as well as many indicators such as Price To Sales Ratio of 1.39, Dividend Yield of 32.3 or PTB Ratio of 0.45. Emeren financial statements analysis is a perfect complement when working with Emeren Valuation or Volatility modules.
Emeren | Deferred Long Term Liab |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Emeren Correlation against competitors. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Construction & Engineering space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Emeren. If investors know Emeren will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Emeren listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.92) | Earnings Share (0.05) | Revenue Per Share 1.915 | Quarterly Revenue Growth (0.11) | Return On Assets (0.01) |
The market value of Emeren Group is measured differently than its book value, which is the value of Emeren that is recorded on the company's balance sheet. Investors also form their own opinion of Emeren's value that differs from its market value or its book value, called intrinsic value, which is Emeren's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Emeren's market value can be influenced by many factors that don't directly affect Emeren's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Emeren's value and its price as these two are different measures arrived at by different means. Investors typically determine if Emeren is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Emeren's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.